CRISPR Medicine News

CMN Intelligence has released the CMN Clinical Trials Q2 2026 Global Report, based on data from the CRISPR Medicine News Global Clinical Trials...

Delivering a CRISPR-Cas-derived adenine base editor as a short-lived protein-guide RNA complex...

CMN Intelligence has released the CMN Clinical Trials Q2 2026 Global Report, based on data from the...

A gene-edited pig kidney kept a patient with end-stage kidney disease dialysis-free for 271 days,...

The US FDA has accepted Intellia Therapeutics’ application for lonvoguran ziclumeran (lonvo-z,...

Rationally engineered chimeric attachment sites raise the efficiency with which the serine integrase...

Delivering CRISPR-Cas9 as mRNA in lipid nanoparticles preserved the fitness and erythroid potential...

A single intravenous dose of the CRISPR-Cas9 therapy CTX310 – developed by CRISPR Therapeutics –...

Some of the best links we picked up around the internet

An new end-to-end nomination workflow improves the nomination of genomic sites that may be...

A biodegradable charge-altering releasable transporter (CART) delivered RNA selectively to the...

Some of the best links we picked up around the internet

Genome-wide CRISPR-Cas9 screens identified hundreds of genes that support or restrict...

CMN x CSGCT Virtual Symposium | Thursday September 3, 2026 | 13:00–15:00 CEST / 19:00–21:00 CST...

A new CRISPR-Cas-derived base editor can simultaneously mutates adenine, cytosine and guanine within...

US regulators have granted RMAT and Fast Track designations to Allogene’s TALEN-edited, allogeneic...

Great to see our founder Jens-Ole Bock speaking at this week's CRISPR Gene Editing Hands-on Workshop...

Copenhagen-based SNIPR reports today that an experimental CRISPR-armed phage therapy was associated...

Researchers have developed a CRISPR-Cas9 method that replaces exons and larger genomic regions...

CRISPR-Cas base editing altered HTT RNA splicing and reduced toxic huntingtin fragments in a mouse...

A hybrid-vesicle delivery platform helped CRISPR-Cas9 selectively kill the caries-associated...

Researchers have engineered probiotic bacteria to produce CRISPR-Cas9 and edit the ROS-generating...

COPENHAGEN, Denmark, August 3, 2026 — CRISPR Medicine News (CMN) and the Chinese Society of Gene &...

An IGI-led consortium has received up to $27.7 million from ARPA-H to develop personalised in vivo...

Three boys with Duchenne muscular dystrophy retained broadly stable motor function one year after...

A six-year-old girl died after receiving an experimental CRISPR-Cas base-editing treatment for a...

Some of the best links we picked up around the internet

A new artificial intelligence–guided strategy can design highly divergent yet functional variants of...

A new review examines how CRISPR–Cas9 genome editing, artificial intelligence and personalised...

Some of the best links we picked up around the internet

A search for new CRISPR enzymes to improve crop breeding has unexpectedly led to a new strategy for...

Epicrispr Biotechnologies has completed enrolment and dose escalation in the first-in-human trial of...

Preliminary Phase 1 data from Fate Therapeutics indicate that its off-the-shelf CAR T-cell therapy,...

Researchers at Ghent University have engineered virus-like particles decorated with anti-CD4...

Sangamo Therapeutics researchers have engineered the serine integrase Bxb1 to insert large DNA...

Researchers have used CRISPR base editing to identify a previously unknown regulatory mechanism in...

Researchers in Denmark have used CRISPR-Cas9 genome editing to generate T cells expressing a...

A perspective article in Nature Reviews Bioengineering outlines how CRISPR-based RNA silencing could...

Some of the best links we picked up around the internet

The first approved CRISPR medicine has now shown similarly strong results in children as young as...

Beam Therapeutics has received U.S. FDA clearance of its Investigational New Drug (IND) application...

Some of the best links we picked up around the internet

Addressing manufacturing bottlenecks in the transition to clinical scale.

A single intravenous dose of Intellia Therapeutics’ in vivo CRISPR-Cas9 therapy lonvoguran...

Updated phase 1 data indicate that a single infusion of Caribou Biosciences' CB-011, an allogeneic...